Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Quin

Explore full profile

AI digital platform that provides comprehensive personalized medical insight to consumers and GP’s, from symptoms and medical complaints

Amsterdam, NetherlandsFounded 2014Health Tech & Medtech
Valuation $100–250M Last recorded · 2021
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Quin and the history behind them.

About Quin

Quin operates as a digital healthcare platform in the Netherlands, designed to function as an intermediary between general practitioners (GPs) and medical specialists to streamline patient care. The company was founded in 2018 by Bart Malenstein, who also serves as the CEO. Malenstein's background includes a lengthy tenure at Bergman Clinics, a major chain of specialized clinics in the Netherlands, where he was CEO and expanded the company significantly. This experience informed the creation of Quin, which initially started as a project within Bergman Clinics to address the unnecessary use of specialized secondary care.

The business provides digital tools for both patients and healthcare professionals to improve the efficiency and quality of care. Quin's business model transitioned from owning and operating physical GP clinics to a licensing model, offering its digital platform to healthcare operators. This shift allows the company to focus on scaling its technology. Revenue is generated through different subscription packages for GP practices, which include features for triage, patient interaction, and consultation, as well as through fee-for-service arrangements for specialist care pathways funded via the Dutch statutory insurance system.

For patients, the Quin app serves as a comprehensive health portal. Key features include an AI-powered symptom checker, the ability to schedule appointments, conduct video consultations, and access personalized medical advice based on their profile and history. The platform aims to give patients more control by providing reliable information and facilitating communication with their doctors. For healthcare providers, Quin offers a web-based application, 'Quin Pro', which integrates with existing GP information systems. This tool supports workflows by providing structured patient data from the app as a check-in, facilitating digital consultations, and offering specialized care pathways for diagnostics, ultimately aiming to reduce the administrative burden on doctors and prevent unnecessary specialist referrals.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2014
Headquarters
Amsterdam, Netherlands
Employees
69
Open positions
2
Dealroom signal
68.1/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Medical Education, Telemedicine, Core AI, Virtual Assistant, Clinical Decision Support, Tech for Medical Professionals, Tech for Patients, Physician Support Tools, Hard Tech
Technology
Artificial Intelligence
Business model
SaaS
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jan 2021 $28M $110M Partners in Equity (PiE) —
SECONDARYOther financing Jan 2019 $11M — ExO Capital —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearProfitMargin
2026 —
2025 —
2024 —
2023 —
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Quin website traffic

Latest recorded traffic for Quin is 13K monthly website visits, down 18.8% over the last three months. Quin's team declined 2.8% over the past year.

Latest monthly visits13K 3-month web change-18.8% 1-year team growth-2.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Partners in Equity (PiE)

Series B and later1 investor entered at this stage

  • ExO Capital

Other known investors1 additional known investor

  • Bergman Clinics
Team profiled 21 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇳🇱 Netherlands97.1%
🇳🇵 Nepal2.9%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Quin on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Quin’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.